Alnylam to Webcast Presentations at Upcoming Investor Conferences
Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018at 10:00 am ETat the Lotte New York Palace Hotelin New York City
Evercore ISI HealthconX on
Wednesday, November 28, 2018at 12:30 pm ETat the Boston Harbor Hotelin Boston
A live audio webcast of each presentation will be available on the Investors section of the Company’s website, www.alnylam.com. A replay will be available on the Alnylam website within 48 hours after each event.
Alnylam (Nasdaq: ALNY) is leading the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS) diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases. Founded in 2002, Alnylam is delivering on a bold vision to turn scientific possibility into reality, with a robust discovery platform. Alnylam’s first U.S.
Alnylam Pharmaceuticals, Inc.
Christine Regan Lindenboom
(Investors and Media)